Transforming growth factor β1 (TGF-β1) in patients with endocrine ophthalmopathy and Graves’ disease: A predictor of treatment efficiency

Current therapeutic approaches to the treatment of endocrine ophthalmopathy (EOP) are based on nonspecific immunosuppression with glucocorticosteroids (GCs) and radiation therapy of the eye orbits. However, some patients exhibit resistance to the treatment. In a previous study, we have detected high...

Celý popis

Podrobná bibliografie

Hlavní autoři:	N. Yu. Sviridenko, E. G. Bessmertnaya, I. M. Belovalova, M. S. Sheremeta, D. M. Babaeva, N. M. Malysheva, E. A. Troshina, G. A. Melnichenko
Médium:	Artigo
Jazyk:	Russo
Vydáno:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2022-11-01
Edice:	Медицинская иммунология
Témata:	graves’ disease endocrine ophthalmopathy cytokines antibodies glucocorticoids
On-line přístup:	https://www.mimmun.ru/mimmun/article/view/2514
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!